Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Glucose Transporters01:27

Glucose Transporters

27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

763
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
763

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic survey of biomarkers at early and mid-pregnancy identifies pregnancy-specialized immune regulation.

PLoS genetics·2026
Same author

Early Pregnancy Blood Pressure Trajectory Groups Predict Hypertensive Disorders of Pregnancy.

JACC. Advances·2026
Same author

Validity of International Classification of Diseases (ICD)-9 and ICD-10 Codes for Medication-Related Osteonecrosis of the Jaw (MRONJ) Among Individuals Prescribed Antiresorptives for Fracture Prevention Across Two Cohorts.

Clinical epidemiology·2026
Same author

Trajectories of reproductive events from menarche to menopause: identifying patterns and differences by childhood maltreatment and socioeconomic position.

American journal of epidemiology·2026
Same author

A comparison of deep multiomics profiles across ethnicity, geography, and age.

Cell·2026
Same author

Stress Granule Sequestration of CCR4-NOT Promotes Poly(A) Lengthening of Stress-Survival Transcripts.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 6, 2026

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

11.4K

Early Postpartum Glucose Tolerance Reclassification by Gestational Diabetes Subtype.

Julie A D Van1,2, Joan C Lo3,4,5, Yeyi Zhu3,5

  • 1Department of Physiology, University of Toronto, Toronto, Ontario, Canada.

JAMA Network Open
|November 10, 2025
PubMed
Summary

Gestational diabetes (GD) subtypes show varying risks for postpartum prediabetes. Women with fasting or mixed GD subtypes face higher risks, suggesting a need for targeted interventions.

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

1.0K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.3K

Related Experiment Videos

Last Updated: Jan 6, 2026

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

11.4K
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

1.0K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.3K

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Public Health

Background:

  • Gestational diabetes (GD) is a complex condition linked to maternal and offspring metabolic disorders.
  • While GD subtypes are known to affect perinatal outcomes, their impact on early postpartum maternal metabolic health remains unclear.

Purpose of the Study:

  • To investigate the early postpartum glucose tolerance reclassification across different gestational diabetes (GD) subtypes.

Main Methods:

  • A cohort study of 1005 women diagnosed with GD using Carpenter and Coustan criteria.
  • Classification of GD into three subtypes: postload glucose intolerance (GD-P), fasting hyperglycemia (GD-F), and mixed (GD-M).
  • Postpartum glucose tolerance assessed 6-9 weeks after delivery using a 2-hour, 75-g oral glucose tolerance test (OGTT); modified Poisson regression used to analyze prediabetes risks.

Main Results:

  • Overall postpartum prediabetes prevalence was 34.5%, with significant variation among GD subtypes.
  • Prediabetes prevalence was 23.9% for GD-P, 41.9% for GD-F, and 55.8% for GD-M.
  • Compared to GD-P, adjusted prevalence ratios for postpartum prediabetes were 1.74 for GD-F and 2.23 for GD-M, indicating significantly higher risks.

Conclusions:

  • Gestational diabetes subtypes exhibit distinct risks for developing postpartum prediabetes.
  • Women with fasting hyperglycemia (GD-F) or mixed (GD-M) gestational diabetes subtypes have a significantly elevated risk of postpartum prediabetes.
  • Early interventions targeting dysglycemia are likely most beneficial for women identified with GD-F or GD-M subtypes.